Article: FDA Clears New Asthma Treatment: ACCOLATE; First New Class of Asthma Drug in 20 Years

Article: Zeneca files New Drug Application for ACCOLATE.
Business Wire;  August 29, 1995 ;     700+ words ... ... Patients treated with ACCOLATE for 13 weeks experienced ... daytime and nocturnal asthma symptoms, and a reduced ... Beneficial effects of ACCOLATE therapy were evident ... decreases in morning asthma symptoms and beta-agonist use. ACCOLATE was well tolerated ...

Article: ACCOLATE -zafirlukast- Approved by FDA for Children with ...
Business Wire;  September 20, 1999 ;     700+ words ... ... Administration in nearly 25 years. ACCOLATE therapy is an oral controller ... Patients on therapy with ACCOLATE take one tablet in the morning ... periods, to help control asthma symptoms all day and all night. ACCOLATE should not be used to reverse ...

Article: New Clinical Study Shows Children Prefer ACCOLATE Tablet ...
PR Newswire;  September 21, 1998 ;     700+ words ... ... g/d); 80 mg bid ACCOLATE plus SDICS (BDP 336 ... in baseline daytime asthma symptoms scores were 16 percent ... patients administered ACCOLATE 40 mg bid plus SDICS ... concluded, "Adding ACCOLATE to inhaled corticosteroids ... patients who experience asthma symptoms while on ...

Article: Study Presented at ATS Demonstrates Flovent(R) (Fluticasone ...
PR Newswire;  May 7, 2000 ;     700+ words ... ... and morning peak flow, than Accolate. Flovent also was associated ... of symptom-free days than Accolate. "This study demonstrated ... treatment regimen and putting Accolate in its place may result in ... the most important causes of asthma symptoms and can lead to recurrent ...

Article: KPR, Zeneca launch Accolate consumer ads
Pharmaceutical Executive;  March 1, 1999 ;     552 words ...WILMINGTON, DE Accolate, Zeneca's oral asthma medication ... playing wind instruments. Accolate (zafirlukast) is a member ... twice daily to manage chronic asthma symptoms. Zeneca says it's positioning Accolate as a therapy to replace or ...

Article: Study Shows Serevent(R) Inhalation Aerosol Provided Better Lung ...
PR Newswire;  June 11, 1999 ;     700+ words ... ... function as measured by morning peak flow than those who used Accolate(R) (zafirlukast). The study is the first to compare ... treated since 1994. Serevent should not be used to treat acute asthma symptoms. Patients must be provided with a short-acting, beta2 ...

Article: New U.S. Clinical Studies Show ACCOLATE To be Effective ...
PR Newswire;  September 22, 1997 ;     700+ words ... ... European studies of the asthma medication ACCOLATE(R) (zafirlukast)(l) continue ... Germany, September 20-24, 1997. ACCOLATE, an oral medication from Zeneca Pharmaceuticals ... September 1996, physicians have prescribed ACCOLATE for more than 480,000 patients in the ...